Showing results (1921-1930 of 2,037) with videos related to
Sort By:
Pageof 204
Prostate Cancer and Prostatic Diseases|October 14, 2021
Characterization of a castrate-resistant prostate cancer xenograft derived from a patient of West African ancestryBrendon M Patierno, Wen-Chi Foo, Tyler Allen, et al.Innovation in Aging|March 2, 2022
Trajectories of Frailty With Aging: Coordinated Analysis of Five Longitudinal StudiesNatalie D Jenkins, Emiel O Hoogendijk, Joshua J Armstrong, et al.Cell Reports|September 22, 2021
DNA methylation is required to maintain both DNA replication timing precision and 3D genome organization integrityQian Du, Grady C Smith, Phuc Loi Luu, et al.NPJ Precision Oncology|January 29, 2025
Genetic ancestry concordant RNA splicing in prostate cancer involves oncogenic genes and associates with recurrenceMuthana Al Abo, Wen-Chi Foo, Lauren E Howard, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 6, 2021
Circulating Tumor Cell Chromosomal Instability and Neuroendocrine Phenotype by Immunomorphology and Poor Outcomes in Men with mCRPC Treated with Abiraterone or EnzalutamideLandon C Brown, Susan Halabi, Joseph D Schonhoft, et al.The Lancet. Oncology|November 12, 2013
Docetaxel and dasatinib or placebo in men with metastatic castration-resistant prostate cancer (READY): a randomised, double-blind phase 3 trialJohn C Araujo, Géralyn C Trudel, Fred Saad, et al.Molecular Cancer Research : MCR|March 14, 2019
E-Cadherin Represses Anchorage-Independent Growth in Sarcomas through Both Signaling and Mechanical MechanismsMohit Kumar Jolly, Kathryn E Ware, Shengnan Xu, et al.Frontiers in Genetics|April 10, 2018
A Meta-Analysis of Genome-Wide Association Studies of Growth Differentiation Factor-15 Concentration in BloodJiyang Jiang, Anbupalam Thalamuthu, Jennifer E Ho, et al.Alzheimer'S & Dementia (New York, N. Y.)|April 10, 2024
The AUstralian multidomain Approach to Reduce dementia Risk by prOtecting brain health With lifestyle intervention study (AU-ARROW): A study protocol for a single-blind, multi-site, randomized controlled trialSamantha L Gardener, Stephanie J Fuller, Sharon L Naismith, et al.Plos Medicine|September 21, 2011
IL28B, HLA-C, and KIR variants additively predict response to therapy in chronic hepatitis C virus infection in a European Cohort: a cross-sectional studyVijayaprakash Suppiah, Silvana Gaudieri, Nicola J Armstrong, et al.Pageof 204